Eritromicina

Lauromicina, Zynerit e altri

Bibliografia - Quali fonti bibliografiche per Eritromicina?

1. Abouesh A. et al., J. Clin. Psychopharmacol., 2002, 22 (1), 71.


2. AIFA, Agenzia Italiana del Farmaco, Farmaci e gravidanza, 2005, Ministero della Salute.


3. Aranko K. et al., Br. J. Clin. Pharmacol., 1994, 38, 363.


4. Ayanian J.Z. et al., Ann. Intern. Med., 1988, 109, 682.


5. Bachman K. et al., Res. Comm. Pathol. Pharmacol., 1984, 46, 207.


6. Balows A., Fraser D., Ann. Intern. Med., 1979, 90, 489.


7. Bartkowski R.R. et al., Clin. Pharmacol. Ther., 1989, 46, 99.


8. Berger T.M. et al., Pediatrics, 1992, 90, 624.


9. Burstein G.R., Clin. Infect. Dis., 1999, 28 Suppl. 1/S66.


10. Caracao Y. et al., J. Rheumatol., 1992, 19, 494.


11. Cohen L.G. et al., Arch. Intern. Med., 1996, 156, 657.


12. Cooper W.O. et al., Obstet. Gynecol., 2002, 100 (1), 101.


13. Cooper W.O et al., Arch. Pediatr. Adolesc. Med., 2002a, 156 (7), 647.


14. Czeizel A.E. et al., Reprod. Toxicol., 1999, 13 (6), 531.


15. Eady E.A. et al., Br. J. Dermatol., 1996, 134, 107.


16. Ellsworth A.J. et al., J. Fam. Pract., 1990, 31, 265.


17. Florido Lopez J.F. et al., Allergy, 1991, 46 (1), 77.


18. Francis H. et al., Clin. Rheumatol., 1984, 3, 243.


19. Friedman H.S., Chest 1982, 82, 202.


20. Gantz N.M. et al., Ann. Intern. Med., 1977, 88, 866.


21. Godin J.R.P. et al., Drug Intell. Clin. Pharm., 1986, 20, 485.


22. Goldschmidt N. et al., Ann. Pharmacother., 2001, 35, 1396.


23. Gouyon J.B. et al., Pediatr. Infect. Dis. J., 1994, 13, 840.


24. Gupta S.K. et al., Br. J. Clin. Pharmacol., 1989, 27, 475.


25. Hassel et al., Ann. Intern. Med., 1991, 115, 69.


26. Hildebrandt R. et al., Eur.J.Clin. Pharmacol, 1984, 26, 485.


27. Hiller A. et al., Br. J. Anaesth., 1990, 65, 826.


28. Iliopoulou A. et al., Br. J. Clin. Pharmacol., 1982, 14, 495.


29. Jensen C. et al., Lancet, 1994, 344, 825.


30. Kallen B.A. et al., Reprod. Toxicol., 2005, 20 (2), 209.


31. Kantola T. et al., Clin. Pharmacol. Ther., 1998, 64, 177.


32. Kataoka M. et al., Eur. J. Pharm. Sci., 2011, disponibile online 22 settembre.


33. Kenyon S. et al., Lancet, 2008, 372 (9646), 1310.


34. Kenyon S. et al., lancet, 2008a, 372 )9646), 1310.


35. Kivisto K.T. et al., Clin. Pharmacol. Ther., 1997, 62, 348.


36. La Force C.F. et al., J. Clin. Immunol., 1983, 72, 34.


37. Lestico M.R., Smith A.D., Am. Health-Syst. Pharm., 1995, 52, 1805.


38. Lindebaum J. et al., NEJM, 1981, 305, 789.


39. Mahon B.E. et al., J. Pediatr., 2002, 139 (3), 380.


40. Martindale, The complete drug reference, ed 32, 1999, Pharmaceutical Press.


41. Matsuda S., Biol. Res. Pregnancy Perinatol., 1984, 5, 57.


42. Mogford N. et al., BMJ, 1994, 309, 1620.


43. Moore MR, Porphyria: drug lists, 1991.


44. Moore T.J. et al., Pediatrics, 2002, 110, e53.


45. Muck W. et al., Eur. J. Clin. Pharmacol., 1998, 53, 469.


46. Muirhead G.J. et al., Br. J. Clin. Pharmacol., 2002, 53 Suppl. 1, 37S.


47. Nattel S. et al., Am. J. Med., 1990, 89, 235.


48. Navarro J.A. et al., Allerg. Clin. Immunol. Intern., 2000, Suppl. 2, 158


49. Nelson M.V. et al., Clin. Pharmacol. Ther., 1990, 47, 166.


50. Noel G.J. et al., J. Clin. Pharmacol., 2004, 44, 464.


51. Packman A.M. et al., Int. J. Dermatol., 1996, 35, 209.


52. Petri M., Allbriton J., J. Rheumatol., 1992, 19 (2), 265.


53. Phillips J.P; et al., J. Clin. Psychopharmacol., 1986, 6, 297.


54. Ragosta M. et al., Am. J. Med., 1989, 86, 465.


55. Ray W.A. et al., NEJM, 2004, 351, 1089.


56. Redington K. et al., Ann. Intern. Med., 1992, 116, 877.


57. Sanfilippo J.A., J. Ped. Sur., 1976, 11, 177.


58. Scchoenerberg R.A. et al., BMJ, 1990, 300, 1375.


59. Schlienger R.G. et al., 2001, 161 (16), 2021.


60. Schwartz J. et al., South Med. J., 1983, 76, 91.


61. Sheperd A.M. et al., Br. J. Clin. Phar,acol., 1977, 4, 315.


62. Siedlik P.H. et al., J. Clin. Pharmacol., 1999, 39, 501.


63. Spach D.H. et al., West J. Med., 1991, 154, 213.


64. Spinler S.A. et al., Clin. Pharmacol. Ther., 1995, 57, 89.


65. Sorensen H.T. et al., Scand. J. Infect. Dis., 2003, 35 (2), 104.


66. Stafstrom C.E. et al., Arch. Pediatr. Adolesc. Med., 1995, 149, 99.


67. Stainforth J. et al., J. Dermatol. Treat., 1993, 4, 119.


68. Tashida S.J. et al., Pharmacotherapy, 1996, 16, 663.


69. Tenenbein M.S., Tenenbein M., Pediatr. Emerg. Care, 2005, 21 (10), 675.


70. Tobe S.W. et al., Cancer Chemother. Pharmacol., 1995, 35, 188.


71. Yasui N. et al., Clin. Pharmacol. Ther., 1996, 59, 514.


72. Wong Y.Y. et al., Clin. Pharmacol. Ther., 1983, 33, 460.


73. Wright A.J. et al., CMAJ, 2011, 183, 303.


74. Wroblewski B.A. et al., JAMA, 1986, 255, 1165.


75. Zhang Y. et al., Zhonghua Fu Chan Ke Za Zhi. 1997, 32, 288.